CN Stock MarketDetailed Quotes

300363 Porton Pharma Solutions

Watchlist

18.44
-0.89-4.60%

Market Closed Nov 15 15:00 CST

10.06BMarket Cap-25682P/E (TTM)

Porton Pharma Solutions Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Porton Pharma Solutions Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q2	674.364M / 1.118B	--
--	2024/Q1	677.718M / 653.000M	--
--	2023/Q4	630.414M / 621.000M	--
--	2023/Q3	698.257M / 796.000M	--
--	2023/Q2	960.944M / 1.256B	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q2674.364M / 1.118B--

--2024/Q1677.718M / 653.000M--

--2023/Q4630.414M / 621.000M--

--2023/Q3698.257M / 796.000M--

--2023/Q2960.944M / 1.256B--

Unlock Free Earnings Estimates

Open Account

Porton Pharma Solutions Earnings Reports

Boteng shares: 2024 third quarter report

Oct 24 12:00 ET

Boteng shares: 2024 semi-annual report

Aug 27 12:00 ET

Boteng Shares: 2024 Semi-Annual Report Summary

Aug 27 12:00 ET

Porton Pharma Solutions: 2024 First Quarter Report

Apr 26 12:00 ET

Analyst Rating

Updated: Nov 16, 2024

Strong Buy

Strong Buy
81.25%
Buy
18.75%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall